Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bionicjoeon Apr 03, 2019 8:27pm

60 Views

Post# 29579492

RE:RE:RE:RE:RE:RE:RE:RE:What happened?

Skier59, what you are proposing would amount to a loophole whereby companies could use the right to try to circumvent the normal FDA testing procedure. Your suggestion is just a twist on the opening of a Mexican clinic that some posters were once saying would be the budget solution to proving the treatment works. Big pharma has one of the most powerful lobbies in the States. They are not going to sit still while a small Canadian company tries to muscle in on their turf assuming the FDA would allow TLT to change the rules that have served them well for decades. You might as well face it if you're going to be a biotech long investor. Things move at a snail's pace and nothing comes cheap.

Bullboard Posts

dynaCERT leans into global growth with new HydraGEN orders